This newly identified ACE2/Ang-(1–7)/Mas axis, which is distinct from the classical RAS pathway, is gaining research importance and has been suggested to act as a negative regulator of Ang II signaling, especially in the attenuation of cardiovascular dysfunction and associated metabolic diseases including diabetes [8,9,10,11]. Here, ANG is linked to diabetes mellitus.